Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Content Provider : Academic Search Ultimate

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

The efficacy and safety of Nusinersen for spinal muscular atrophy types 1, 2, 3: a systematic review of the current evidence.

Authors : Daghriri, Somaia¹ (AUTHOR) ; Alorfi, Yara A.² (AUTHOR) ; Alayed, Rasil Sulaiman³ (AUTHOR)

Source: Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 4/24/2025, Vol. 61 Issue 1, p1-10. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

A perioperative nursing care protocol for patients with spinal muscular atrophy (SMA) type II or type III undergoing spinal surgery: a 4-year experience in 24 patients.

Authors : Li, Gaoyang^1,2,3 (AUTHOR); Xu, Kexin^1,2,3 (AUTHOR); Liu, Di^1,2,3 (AUTHOR)

Source: Orphanet Journal of Rare Diseases. 5/19/2025, Vol. 20 Issue 1, p1-10. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.

Authors : Belančić, Andrej¹ (AUTHOR) ; Mas, Petar² (AUTHOR); Miletić, Lara^1,2 (AUTHOR)

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 9, p3173. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan.

Authors : Wang, Chen-Hua^1,2,3 (AUTHOR); Hsu, Ting-Rong^4,5 (AUTHOR); Liu, Mei-Ying⁶ (AUTHOR)

Source: Orphanet Journal of Rare Diseases. 4/24/2025, Vol. 20 Issue 1, p1-12. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Enhancing the effects of nusinersen with cybernic treatment using Hybrid Assistive Limb (HAL) in spinal muscular atrophy: a real-world case series and exploratory cohort analysis.

Authors : Nakajima, Takashi¹ (AUTHOR) ; Saito, Toshio² (AUTHOR); Hashiguchi, Akihiro³ (AUTHOR)

Source: Orphanet Journal of Rare Diseases. 4/23/2025, Vol. 20 Issue 1, p1-15. 15p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Operative treatment of severe scoliosis and pelvic obliquity in patients with spinal muscular atrophy: assessment of outcomes and complications.

Authors : Sun, Heng¹ (AUTHOR); Huang, Yizhen¹ (AUTHOR); Dong, Yulei¹ (AUTHOR)

Source: Orphanet Journal of Rare Diseases. 4/11/2025, Vol. 20 Issue 1, p1-11. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Long-read sequencing identifies copy-specific markers of SMN gene conversion in spinal muscular atrophy.

Authors : Zwartkruis, M. M.^1,2 (AUTHOR); Elferink, M. G.² (AUTHOR); Gommers, D.^1,2 (AUTHOR)

Source: Genome Medicine. 3/21/2025, Vol. 17 Issue 1, p1-18. 18p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Adiponectin and Leptin—Considerations in Adult Patients with Spinal Muscular Atrophy Type 3.

Authors : Miletić, Marija^1,2 (AUTHOR); Stević, Zorica^2,3 (AUTHOR); Perić, Stojan^2,3 (AUTHOR)

Source: Diagnostics (2075-4418). Mar2025, Vol. 15 Issue 5, p529. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications.

Authors : Belančić, Andrej¹ (AUTHOR) ; Janković, Tamara^1,2 (AUTHOR); Gkrinia, Elvira Meni Maria^2,3 (AUTHOR)

Source: Neurology International. Mar2025, Vol. 17 Issue 3, p41. 41p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Impact of Nusinersen on the Health-Related Quality of Life and Caregiver Burden in Patients with Spinal Muscular Atrophy with Symptom Onset before the Age of 6 Months.

Authors : Lee, Yun Jeong¹ (AUTHOR); Bae, Hyunwoo² (AUTHOR); Shim, Young Kyu³ (AUTHOR)

Source: Annals of Child Neurology. Apr2025, Vol. 33 Issue 2, p39-47. 9p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

The efficacy and safety of Nusinersen for spinal muscular atrophy types 1, 2, 3: a systematic review of the current evidence.

A perioperative nursing care protocol for patients with spinal muscular atrophy (SMA) type II or type III undergoing spinal surgery: a 4-year experience in 24 patients.

Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.

Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan.

Enhancing the effects of nusinersen with cybernic treatment using Hybrid Assistive Limb (HAL) in spinal muscular atrophy: a real-world case series and exploratory cohort analysis.

Operative treatment of severe scoliosis and pelvic obliquity in patients with spinal muscular atrophy: assessment of outcomes and complications.

Long-read sequencing identifies copy-specific markers of SMN gene conversion in spinal muscular atrophy.

Adiponectin and Leptin—Considerations in Adult Patients with Spinal Muscular Atrophy Type 3.

Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications.

Impact of Nusinersen on the Health-Related Quality of Life and Caregiver Burden in Patients with Spinal Muscular Atrophy with Symptom Onset before the Age of 6 Months.

Contact

Follow us